HRCVX | VIVAX | HRCVX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 38 years | 32 years | - |
Gain YTD | 15.629 | 14.000 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 572M | 195B | 0% |
Annual Yield % from dividends | 1.46 | 2.25 | 65% |
Returns for 1 year | 17.05 | 15.15 | 113% |
Returns for 3 years | -2.33 | 18.25 | -13% |
Returns for 5 years | 14.85 | 41.35 | 36% |
Returns for 10 years | 42.45 | 99.53 | 43% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KDHIX | 54.12 | 0.65 | +1.22% |
DWS CROCI Equity Dividend Inst | |||
PEEAX | 15.21 | 0.18 | +1.20% |
PGIM Jennison Mid-Cap Growth A | |||
THPBX | 23.60 | 0.21 | +0.90% |
BNY Mellon Balanced Opportunity J | |||
SEKCX | 16.25 | 0.11 | +0.68% |
DWS Emerging Markets Equity C | |||
MGICX | 30.04 | 0.17 | +0.57% |
MFS International Intrinsic Value C |